Table 1.
Demographic, clinic, and laboratory features of the study groups
| Group A: Controlled DM without microalbuminuria | Group B: Uncontrolled DM without microalbuminuria | Group C: DM with microalbuminuria | P value | |
|---|---|---|---|---|
| Mean ± Std. Dev | Mean ± Std. Dev | Mean ± Std. Dev | ||
| Age (y) | 64 ± 11 | 61 ± 10 | 67 ± 10 | .02 |
| Years of diabetes | 10 ± 6 | 14 ± 8 | 15 ± 7 | .01 |
| Male/female (N) | 24/29 | 27/30 | 33/25 | |
| BMI (kg/m2) | 28.81 ± 5.64 | 29.06 ± 4.73 | 29.80 ± 4.97 | .56 |
| HbA1c (%) | 6.30 ± 0.46 | 8.43 ± 1.08 | 8.54 ± 1.66 | .00 |
| MAP (mm Hg) | 96 ± 8 | 96 ± 9 | 96 ± 9 | .8 |
| Albumin (g/dL) | 4.28 ± 0.34 | 4.24 ± 0.33 | 4.21 ± 0.34 | .60 |
| Serum creatinine (mg/dL) | 0.80 ± 0.19 | 0.82 ± 0.24 | 1.11 ± 0.47 | .00 |
| TG/HDL ratio | 2.87 ± 1.68 | 4.36 ± 3.12 | 4.61 ± 3.46 | .04 |
| LDL‐C (mg/dL) | 87.95 ± 28.43 | 83.53 ± 36.31 | 85.59 ± 31.13 | .77 |
| microalbumin:creatinine ratio (mcg/mg) | 6.15 ± 5.77 | 8.37 ± 6.95 | 228.79 ± 327.56 | .00 |
| NLR | 1.90 ± 0.65 | 2.06 ± 0.83 | 2.60 ± 1.19 | <.001 |
| MPV (fL) | 9.96 ± 1.53 | 10.06 ± 1.53 | 10.09 ± 1.44 | .88 |
| RDW (%) | 14.04 ± 0.98 | 13.85 ± 1.17 | 14.48 ± 1.34 | .016 |
Abbreviations: BMI, body mass index; DM, diabetes mellitus; HbA1c, glycated hemoglobin; LDL‐C, low‐density lipoprotein cholesterol level; MAP, mean arterial pressure; MPV, mean platelet volume; N, number of patients included per group; NLR, neutrophil‐to‐lymphocyte ratio; RDW, red blood cell distribution width; Std. Dev, standard deviation; TG/HDL ratio, triglyceride (TG) to high‐density lipoprotein (HDL).